The gap between guidelines and practice in the treatment of type 2 diabetes. A nationwide survey in Norway

Diabetes Research and Clinical Practice

Volumn 80, Issue 2, 2008, Pages 314-320

  Jenssen, Trond G ^a,f   Tonstad, Serena ^b   Claudi, Tor ^c   Midthjell, Kristian ^d   Cooper, John ^e  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c Rønvik Health Center   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^e STAVANGER UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Diabetes complications; Management; Metabolic syndrome

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; HEMOGLOBIN A1C; LIPID; ORAL ANTIDIABETIC AGENT; SALICYLIC ACID;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ERECTILE DYSFUNCTION; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METABOLIC SYNDROME X; MICROALBUMINURIA; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREVALENCE; RANDOMIZATION; RISK FACTOR; WORLD HEALTH ORGANIZATION;

EID: 41849103788     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.12.025     Document Type: Article

References (24)

1. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. Midthjell K., Krüger Ø., Holmen J., et al. Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997. Diabetes Care 22 (1999) 1813-1820
3. Pyörälä K., Laakso M., and Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view (Review). Diabetes Metab. Rev. 3 (1987) 463-524
4. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 (1993) 434-444
5. Lehto S., Rönnemaa T., Haffner S.M., et al. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 46 (1997) 1354-1359
6. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317 (1998) 703-713
7. Collins R., Armitage J., Parish S., et al. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361 (2003) 2005-2016
8. Colhoun H.M., Betteridge D.J., Durrington P.N., et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364 (2003) 685-696
9. Gaede P., Vedel P., Larsen N., et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348 (2003) 383-393
10. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
11. Ohkubo Y., Kishikawa H., Araki E., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diab. Res. Clin. Pract. 28 (1995) 103-117
12. Claudi T., Cooper J.G., Midthjell K., et al. NSAM's guidelines for treatment of diabetes in general practice. Oslo: Norwegian College of General Practitioners, Norwegian Institute of Public Health, Norwegian Medical Association. Norwegian Diabetes Assoc. (2000) (in Norwegian)
13. European Diabetes Policy Group 1999. A desktop guide to type 2 diabetes mellitus. Diabet. Med. 16 (1999) 716-730
14. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur. Heart J. 28 (2007) 88-136
15. Report of a WHO consultation, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, Genève: WHO, 1999.
16. Hoelzel W., Weykamp C., Jeppsson J.O., et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison. Clin. Chem. 50 (2004) 166-174
17. Eliasson B., Cederholm J., Nilsson P., and Gudbjörnsdottir S. The gap between guidelines and reality: Type 2 diabetes in a national register 1996-2003. Diabet. Med. 22 (2005) 1420-1426
18. Koro C.E., Bowlin S.J., Bourgeois N., and Fedder D.O. Glycaemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes. Diabetes Care 27 (2004) 17-20
19. Tonstad S., Rosvold E.O., Furu K., and Skurtveit S. Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001. J. Int. Med. 255 (2004) 494-502
20. Kempen J.H., O'Colmain B.J., Leske M.C., et al. Eye Disease Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch. Ophthalmol. 122 (2004) 552-563
21. McGill J.B., Brown W.W., Chen S.C., et al. Kidney early evaluation program (KEEP). Findings from a community screening program. Diabetes Educ. 30 (2004) 196-198 200-202
22. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
23. Saydah S.H., Fradkin J., and Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291 (2004) 335-342
24. Claudi T., Cooper J.G., Hausken M.F., et al. Risk intervention in persons with diabetes mellitus in general practice. Tidsskr. Nor. Laegeforen. 124 (2004) 1508-1510 (in Norwegian with an English summary)